Nicotine depedence and salivary cotinine concentration in daily smokers

European Journal of Cancer Prevention

Volumn 21, Issue 1, 2012, Pages 96-102

  Fu, Marcela ^a,b,d   Martínez Sánchez, Jose M ^a,b,d   Agudo, Antoni ^a,c   Pascual, José A ^e,f   Ariza, Carles ^g,h   Moncada, Albert ⁱ   Fernández, Esteve ^a,b,d  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b Cancer Control and Prevention Group   (Spain)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e HOSPITAL DEL MAR   (Spain)

^f UNIVERSITAT POMPEU FABRA   (Spain)

^g AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^h CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

ⁱ Terrassa City Council   (Spain)

Author keywords

Cotinine; Cross sectional study; Dependence; Epidemiology; Smoking

Indexed keywords

COTININE; NICOTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CIGARETTE SMOKING; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SALIVA LEVEL; SCORING SYSTEM; TOBACCO;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; COTININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PROGNOSIS; QUESTIONNAIRES; SALIVA; SMOKING; SPAIN; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 82555183076     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834a7e59     Document Type: Article

References (35)

1. Becoña E, Vazquez FL (1998). The Fagerström Test for Nicotine Dependence in a Spanish sample. Psychol Rep 83:1455-1458. (Pubitemid 128463140)
2. Benowitz NL (1996). Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18:188-204. (Pubitemid 27082089)
3. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P III (2006). Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther 79:480-488.
4. Blackford AL, Yang G, Hernandez-Avila M, Przewozniak K, ZatonskiW, Figueiredo V, et al. (2006). Cotinine concentration in smokers from different countries: relationship with amount smoked and cigarette type. Cancer Epidemiol Biomarkers Prev 15:1799-1804. (Pubitemid 44664251)
5. Caraballo RS, Giovino GA, Pechacek TF, Mowery PD, Richter PA, Strauss WJ, et al. (1998). Racial and ethnic differences in serum cotinine levels of cigarette smokers. Third National Health and Nutrition Examination Survey, 1988-1991. JAMA 280:135-139. (Pubitemid 28498384)
6. de Leon J, Becoña E, Gurpegui M, Gonzalez-Pinto A, Diaz FJ (2002). The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry 63:812-816.
7. Dempsey D, Tutka P, Jacob P III, Allen F, Schoedel K, Tyndale RF, et al. (2004). Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther 76:64-72. (Pubitemid 38844735)
8. Diaz FJ, Jané M, SaltóE, Pardell H, Salleras L, Pinet C, et al. (2005). A brief measure of high nicotine dependence for busy clinicians and large epidemiological surveys. Aust N Z J Psychiatry 39:161-168. (Pubitemid 40425721)
9. Fagerström K, Furberg H (2008). A comparison of the Fagerström test for nicotine dependence and smoking prevalence across countries. Addiction 103:841-845. (Pubitemid 351537692)
10. Fagerstrom KO, Heatherton TF, Kozlowski LT (1990). Nicotine addiction and its assessment. Ear Nose Throat J 69:763-765.
11. Fagerström KO, Kunze M, Schoberberger R, Breslau N, Hughes JR, Hurt RD, et al. (1996). Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control 5:52-56. (Pubitemid 126670503)
12. Fernandez E (2006). Spain: going smoke free. Tob Control 15:79-80.
13. Fernandez E, Pascual JA, Schiaffino A, Fu M, Twose J, Moncada A, et al. (2007). Validity of a questionnaire on self-perceived exposure to secondhand smoke. Gac Sanit 21:22.
14. Fu M, Fernandez E, Martinez-Sanchez JM, Pascual JA, Schiaffino A, Agudo A, et al. (2009). Salivary cotinine concentrations in daily smokers in Barcelona, Spain: a cross-sectional study. BMC Public Health 9:320.
15. Gallus S, La Vecchia C (2004). A population-based estimate of tobacco dependence. Eur J Public Health 14:93-94. (Pubitemid 38523669)
16. Gallus S, Pacifici R, Colombo P, La Vecchia C, Garattini S, Apolone G, et al. (2005). Tobacco dependence in the general population in Italy. Ann Oncol 16:703-706. (Pubitemid 40767089)
17. Gerstenkorn A (2000). Nicotine dependence among the population of a big Polish city. Soz Praventivmed 45:279-282. (Pubitemid 32051447)
18. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J (1989). Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 84:791-799.
19. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO (1991). The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 86:1119-1127.
20. Henningfield JE, Benowitz NL (2004). Pharmacology of nicotine addiction. In: Boyle P, Gray N, Henningfield J, Seffrin J, Zatonski W, editors. Tobacco and public health: science and policy. Oxford: Oxford University Press. pp. 129-147.
21. Joseph AM, Hecht SS, Murphy SE, Carmella SG, Le CT, Zhang Y, et al. (2005). Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev 14:2963-2968. (Pubitemid 43071219)
22. Klesges RC, Debon M, Ray JW (1995). Are self-reports of smoking rate biased? Evidence from the Second National Health and Nutrition Examination Survey. J Clin Epidemiol 48:1225-1233.
23. Lessov-Schlaggar CN, Benowitz NL, Jacob P, Swan GE (2009). Genetic influences on individual differences in nicotine glucuronidation. Twin Res Hum Genet 12:507-513.
24. Lopez AD, Collishaw NE, Piha T (1994). A descriptive model of the cigarette epidemic in developed countries. Tob Control 3:242-247.
25. Malaiyandi V, Goodz SD, Sellers EM, Tyndale RF (2006). CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking. Cancer Epidemiol Biomarkers Prev 15:1812-1819. (Pubitemid 44664253)
26. Melikian AA, Djordjevic MV, Hosey J, Zhang J, Chen S, Zang E, et al. (2007). Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke. Nicotine Tob Res 9:377-387. (Pubitemid 46404269)
27. Pascual JA, Diaz D, Segura J, Garcia-Algar O, Vall O, Zuccaro P, et al. (2003). A simple and reliable method for the determination of nicotine and cotinine in teeth by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 17:2853-2855. (Pubitemid 38029331)
28. Pauly JR (2008). Gender differences in tobacco smoking dynamics and the neuropharmacological actions of nicotine. Front Biosci 13:505-516. (Pubitemid 351599761)
29. Shin HS, Kim JG, Shin YJ, Jee SH (2002). Sensitive and simple method for the determination of nicotine and cotinine in human urine, plasma and saliva by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 769:177-183.
30. Strong K, Guthold R, Yang J, Lee D, Petit P, Fitzpatrick C (2008). Tobacco use in the European region. Eur J Cancer Prev 17:162-168. (Pubitemid 351301628)
31. Swan GE, Lessov-Schlaggar CN, Bergen AW, He Y, Tyndale RF, Benowitz NL (2009). Genetic and environmental influences on the ratio of 3'hydroxycotinine to cotinine in plasma and urine. Pharmacogenet Genomics 19: 388-398.
32. US Department of Health and Human Services (1988). The health consequences of smoking. Nicotine addiction. A report of the Surgeon General. Washington DC: US Government Printing Office.
33. Villalbí JR, Rodríguez-Sanz M, Villegas R, Borrell C (2009). Changes in the population smoking patterns: Barcelona, 1983-2006. Med Clin (Barc) 132:414-419.
34. West R (2004). Assessment of dependence and motivation to stop smoking. BMJ 328:338-339. (Pubitemid 38197858)
35. West O, Hajek P, McRobbie H (2011). Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence. Psychopharmacology (Berl)(In press). DOI: 10.1007/s00213-011-2341-1